24 Sep 2025 Enhertu plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer Multiple categories
11 Jun 2025 Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
